Pure Global
NCT03980847

Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket

Teh Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in Teh Preservation of Teh Tooth Socket
Islamic Azad University, Tehran·Phase 2·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bone Resorption
Drug/Device/Intervention
Alendronate 20 mg
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Islamic Azad University, Tehran
Location
Tehran, Iran
Timeline & enrollment
Phase
Phase 2
Start date
Feb 23, 2018
End date
Apr 25, 2019
Enrollment
20 participants
Primary outcome

New bone formation (bone area as percent)

Summary

Twenty patients referring to periodontics department of Boroujerd Azad university of
 dentistry after obtaining consent to participate in teh research project, which TEMPhas more
 TEMPthan 20 teeth, are over 18 years old and require socket preservation surgery to tooth
 extraction for teh periodontal problem, caries or Fractures were selected.

ICD-10 classifications
OsteolysisPathological resorption of teethBone donorPostsurgical malabsorption osteoporosisPostsurgical malabsorption osteoporosis with pathological fracture
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03980847
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03980847 through Pure Global AI's free database. This Phase 2 trial is sponsored by Islamic Azad University, Tehran and is currently Completed. The study focuses on Bone Resorption. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.